These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16199549)
1. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). Krüger S; Bier A; Engel C; Mangold E; Pagenstecher C; von Knebel Doeberitz M; Holinski-Feder E; Moeslein G; Schulmann K; Plaschke J; Rüschoff J; Schackert HK; J Med Genet; 2005 Oct; 42(10):769-73. PubMed ID: 16199549 [TBL] [Abstract][Full Text] [Related]
2. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Krüger S; Engel C; Bier A; Silber AS; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Royer-Pokora B; Dechant S; Pox C; Rahner N; Müller A; Schackert HK; Cancer Lett; 2007 Jul; 252(1):55-64. PubMed ID: 17224235 [TBL] [Abstract][Full Text] [Related]
3. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. Krüger S; Silber AS; Engel C; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Moeslein G; Dietmaier W; Stemmler S; Friedl W; Rüschoff J; Schackert HK; Lancet Oncol; 2005 Aug; 6(8):566-72. PubMed ID: 16054567 [TBL] [Abstract][Full Text] [Related]
4. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
5. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
7. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene. Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003 [TBL] [Abstract][Full Text] [Related]
8. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994 [TBL] [Abstract][Full Text] [Related]
9. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354 [TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
12. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia. Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210 [TBL] [Abstract][Full Text] [Related]
14. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814 [TBL] [Abstract][Full Text] [Related]
15. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Jones JS; Chi X; Gu X; Lynch PM; Amos CI; Frazier ML Clin Cancer Res; 2004 Sep; 10(17):5845-9. PubMed ID: 15355915 [TBL] [Abstract][Full Text] [Related]
16. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Mueller-Koch Y; Vogelsang H; Kopp R; Lohse P; Keller G; Aust D; Muders M; Gross M; Daum J; Schiemann U; Grabowski M; Scholz M; Kerker B; Becker I; Henke G; Holinski-Feder E Gut; 2005 Dec; 54(12):1733-40. PubMed ID: 15955785 [TBL] [Abstract][Full Text] [Related]
17. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia. Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052 [TBL] [Abstract][Full Text] [Related]
18. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164 [TBL] [Abstract][Full Text] [Related]
19. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128 [TBL] [Abstract][Full Text] [Related]
20. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]